HETEROGENEITY OF THE TYPE I INTERFERON SIGNATURE IN RHEUMATOID ARTHRITIS MAY ACCOUNT FOR DIFFERENCES IN ITS CLINICAL RELEVANCE

被引:0
|
作者
Rodriguez-Carrio, J. [1 ,2 ]
Alperi-Lopez, M. [2 ,3 ]
Lopez, P. [1 ,2 ]
Ballina-Garcia, F. J. [2 ,3 ]
Suarez, A. [1 ,2 ]
机构
[1] Univ Oviedo, Area Immunol, Oviedo, Spain
[2] Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain
[3] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Spain
关键词
D O I
10.1136/annrheumdis-2018-eular.3195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0041
引用
收藏
页码:1220 / 1221
页数:2
相关论文
共 50 条
  • [1] Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker
    Rodriguez-Carrio, Javier
    Alperi-Lopez, Mercedes
    Lopez, Patricia
    Ballina-Garcia, Francisco J.
    Suarez, Ana
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [2] On the Origin of the Type I Interferon Signature in Rheumatoid Arthritis
    de Jong, T. D.
    Vosslamber, Saskia
    Eloranta, Maija-Leena
    Ronnblom, Lars
    Gelderman, Kyra
    von Blomberg, Mary
    Bultink, Irene
    Voskuyl, Alexandre
    Verweij, Cornelis L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S770 - S771
  • [3] Clinical relevance of the type I interferon signature in multiple sclerosis
    Verweij, Cornelis L.
    PHARMACOGENOMICS, 2012, 13 (16) : 1883 - 1884
  • [4] THE RELATIONSHIP BETWEEN THE TYPE I INTERFERON SIGNATURE AND THE RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS
    Thurlings, R. M.
    Boumans, M.
    Tekstra, J.
    Vos, K.
    van Westing, D. M.
    van Baarsen, L. G.
    Bos, C.
    Kirou, K. A.
    Gerlag, D. M.
    Crow, M. K.
    Verweij, C. L.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69
  • [5] Interferon Type I Signature Predicts Non Response to Rituximab in Rheumatoid Arthritis.
    Raterman, Hennie G.
    Vosslamber, Saskia
    Nurmohamed, Michael T.
    Lems, Willem F.
    Boers, Maarten
    Dijkmans, Ben A. C.
    Verweij, Cornelis L.
    Voskuyl, Alexandre E.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S167 - S167
  • [6] Relationship Between the Type I Interferon Signature and the Response to Rituximab in Rheumatoid Arthritis Patients
    Thurlings, Rogier M.
    Boumans, Marie
    Tekstra, Janneke
    van Roon, Joel A.
    Vos, Koen
    van Westing, Daisy Marie
    van Baarsen, Lisa G.
    Bos, Carina
    Kirou, Kyriakos A.
    Gerlag, Danielle M.
    Crow, Mary K.
    Bijlsma, Johannes W.
    Verweij, Cornelis L.
    Tak, Paul P.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (12): : 3607 - 3614
  • [7] EFFECT OF PREDNISONE ON TYPE I INTERFERON SIGNATURE IN RHEUMATOID ARTHRITIS: CONSEQUENCES FOR RESPONSE PREDICTION TO RITUXIMAB
    de Jong, T. D.
    Vosslamber, S.
    Blits, M.
    Wolbink, G.
    Nurmohamed, M. T.
    van der Laken, C. J.
    Jansen, G.
    Mantel, E.
    Lubbers, J.
    de Ridder, S.
    Voskuyl, A. E.
    Verweij, C. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A80 - A80
  • [8] Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
    de Jong, Tamarah D.
    Vosslamber, Saskia
    Blits, Marjolein
    Wolbink, Gertjan
    Nurmohamed, Mike T.
    van der Laken, Conny J.
    Jansen, Gerrit
    Voskuyl, Alexandre E.
    Verweij, Cornelis L.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [9] Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
    Tamarah D de Jong
    Saskia Vosslamber
    Marjolein Blits
    Gertjan Wolbink
    Mike T Nurmohamed
    Conny J van der Laken
    Gerrit Jansen
    Alexandre E Voskuyl
    Cornelis L Verweij
    Arthritis Research & Therapy, 17
  • [10] ON THE ORIGIN OF THE TYPE I INTERFERON ACTIVITY IN RHEUMATOID ARTHRITIS
    de Jong, T. D.
    Vosslamber, S.
    Eloranta, M. L.
    Ronnblom, L.
    Mantel, E.
    Gelderman, K. A.
    von Blomberg, M. E.
    Bultink, I. E.
    Voskuyl, A. E.
    Verweij, C. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A79 - A79